TY  - JOUR

T1  - Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma.

JO  - Journal of Clinical Oncology

PY  - 2021/02/20

AU  - Hussain SA

AU  - Shimizu N

AU  - Obara W

AU  - Yamasaki T

AU  - Takashima S

AU  - Hasegawa T

AU  - Iguchi M

AU  - Igarashi K

AU  - Ogawa O

AU  - Fujioka T

ED  - 

DO  - DOI: 10.1200/jco.2021.39.6_suppl.440

PB  - American Society of Clinical Oncology (ASCO)

VL  - 39

IS  - 6_suppl

SP  - 440

EP  - 440

Y2  - 2025/01/13

ER  -